Treatment requires selectivity to promote apoptosis only of targeted cancer cells. Selective Photo-Apoptosis exploits the differences in light absorption of the target vs. healthy or non-targeted tissue.
Infrared light, is perceived as warmth from sources such as the sun and furnaces. Infrared light is significantly safer than ionizing radiation used for x-rays and other cancer therapies.
Selective Photo-Apoptosis uses infrared light to avoid the side effects of drugs, chemicals or ionizing radiation. The primary side effect of infrared light is heat which is avoided by Photometics laser’s ultrashort (femtosecond) pulses.
Ultrafast (femtosecond lasers) today are either lower power, higher repetition rate fiber lasers or very unstable and finicky higher power lower repetition rate lasers. Imagine picking up a sheet of plywood, even a very thick one, by the corner and you’ll see that it flexes quite a bit. Now if you image a 2 foot diameter round piece of the same plywood, you’ll note it is incredibly stiff and unbendable. Today’s state-of-the-art high power ultrashort pulse lasers are implemented on 4’ by 8’ optical tables which appear to be very solid, but, like the plywood, they do flex. That flex happens even if the temperature in the room changes by more than 2 degrees Celsius. This is what makes these lasers inherently unstable.
Photometics’ patented laser platform (Photometics EICOP Laser Platform Patent) is bringing the next generation of laser capability to medicine, aesthetics, research, education, industry and the military with both high power and low repetition rate in a rugged, stable and transportable package. Our cylindrical optical platform creates a three-dimensional space that is super rigid with a much smaller footprint while allowing for movement with superior stability.